ChartNet trains AI to read charts, boosting smaller models past commercial rivals

To accelerate and refine decision-making in a fast-paced, global marketplace, enterprises may deploy generative artificial intelligence models to help summarize and interpret the charts that often fill market summaries and financial reports.

But even the latest vision-language models sometimes struggle with this task, since it requires a model to integrate visual, numerical, and linguistic understanding. A company that invests in a state-of-the-art model might still receive inaccurate or incomplete information.

To fill this performance gap, researchers from MIT and the MIT-IBM Computing Research Lab developed a multifaceted resource for AI users that is specifically designed to teach vision-language models (VLMs) how to effectively interpret charts.

They used a novel data gen...

Read More

We can predict space weather—what if we could also stop it?

solar flare
Credit: CC0 Public Domain

The weather on Earth can get pretty messy sometimes. But in space, it can be wild, and the effects can be far-reaching. Solar flares, giant explosions on the sun, can send out streams of energy that block radio communications and fry satellite electronics. Geomagnetic storms, caused by variations in solar wind, can mess with GPS signals and spark current surges on Earth that overload power grids.

The impact of space weather isn’t limited to temporarily losing electricity or digging out dusty paper maps for directions when satellite navigation systems fail. Every electronic financial transaction in the world, for instance, relies on time stamps sent by satellite systems...

Read More

Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows

prostate cancer
Credit: Artem Podrez from Pexels

A Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Cancer Institute and professor of internal medicine at the University of Utah (the U), has found that a combination prostate cancer treatment could prevent the disease from progressing into a harder-to-treat form of cancer in select patients.

Combination therapy targets gene-altered tumors
The study, TALAPRO-3 (NCT04821622), evaluated a combination of two drugs—talazoparib and enzalutamide—in patients with metastatic castration-sensitive prostate cancer. This is a form of the disease that has spread beyond the prostate but remains susceptible to standard hormone therapy treatment.

The patients involved also had prostate cancer affected ...

Read More

World-first spintronic p-bit on silicon chip points toward larger AI-ready p-computers

Spintronics P-computer ready for scale-up
Photograph of test chips fabricated on a silicon substrate using semiconductor integrated circuit manufacturing processes. Credit: Shunsuke Fukami, William A. Borders et al

A Japan–U.S. collaborative research team has demonstrated the world’s first integrated spintronic probabilistic bit, or p-bit, fabricated on a silicon chip using semiconductor manufacturing processes. The team, consisting of researchers from Tohoku University and the National Institute of Standards and Technology, experimentally verified the operation of the p-bit, a key building block for probabilistic, or p-, computers. The achievement provides a pathway toward large-scale spintronic p-computers for applications such as AI and machine learning.

Many emerging computational problems require efficient exploratio...

Read More